Pathogenesis and management of renovascular hypertension and ischemic nephropathy

被引:0
|
作者
Yerram, P. [1 ]
Karuparthi, P. R. [2 ]
Chaudhary, K. [1 ,3 ]
机构
[1] Univ Missouri, Div Nephrol, Dept Internal Med, Columbia, MO 65201 USA
[2] Univ Missouri, Div Cardiol, Dept Internal Med, Columbia, MO 65201 USA
[3] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA
关键词
Renal artery obstruction; Hypertension; renovascular; Kidney disease; RENAL-ARTERY STENOSIS; CAPTOPRIL RENOGRAPHY; BALLOON ANGIOPLASTY; STENT REVASCULARIZATION; FIBROMUSCULAR DYSPLASIA; DIABETIC-NEPHROPATHY; MR-ANGIOGRAPHY; CT ANGIOGRAPHY; FOLLOW-UP; DISEASE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renovascular disease is an important cause of secondary hypertension and renal impairment. Atherosclerotic renal artery stenosis (ARAS) is the most important cause of renal artery stenosis (RAS), and has been linked to increased cardiovascular risk. The pathogenesis of renovascular hypertension is complex, but is mainly due to the over-activation of Renin-Angiotensin-Aldosterone system. A major consequence of untreated RAS is ischemic nephropathy, which is due to the sustained reduction in renal perfusion leading to derangement of microvascular function, and eventual development of interstitial fibrosis. Diagnosis of these conditions can be complex, sometimes needing invasive testing. Aggressive medical management is key to preventing progression of disease, as the role of revascularization in the management of ARAS is still not well defined.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [21] MANAGEMENT OF PATIENT WITH RENOVASCULAR HYPERTENSION
    YOUNGBERG, SP
    SHEPS, SG
    STRONG, CG
    AMERICAN HEART JOURNAL, 1977, 94 (06) : 785 - 794
  • [22] OPERATIVE MANAGEMENT OF RENOVASCULAR HYPERTENSION
    MCCOMBS, PR
    BERKOWITZ, HD
    ROBERTS, B
    ANNALS OF SURGERY, 1975, 182 (06) : 762 - 766
  • [23] Vaccarin alleviates hypertension and nephropathy in renovascular hypertensive rats
    Cai, Weiwei
    Zhang, Zhenpeng
    Huang, Yiqi
    Sun, Haijian
    Qiu, Liying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (01) : 924 - 932
  • [24] Renovascular hypertension modifies the adryamicin nephropathy progression.
    Balbi, A
    Barretti, P
    FerrariSpadotto, A
    Fabio, S
    Franco, R
    HYPERTENSION, 1997, 29 (03) : 145 - 145
  • [25] Resistive index: an ideal test for renovascular disease or ischemic nephropathy?
    Jörg Radermacher
    Nature Clinical Practice Nephrology, 2006, 2 : 232 - 233
  • [26] Resistive index: an ideal test for renovascular disease or ischemic nephropathy?
    Radermacher, J
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (05): : 232 - 233
  • [28] Redox Signaling Is an Early Event in the Pathogenesis of Renovascular Hypertension
    Hartono, Stella P.
    Knudsen, Bruce E.
    Zubair, Adeel S.
    Nath, Karl A.
    Textor, Stephen J.
    Lerman, Lilach O.
    Grande, Joseph P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) : 18640 - 18656
  • [29] INDICATIONS FOR OPERATIVE MANAGEMENT OF RENOVASCULAR HYPERTENSION
    DEAN, RH
    JOURNAL OF THE SOUTH CAROLINA MEDICAL ASSOCIATION, 1977, 73 (12): : 523 - 525
  • [30] RENOVASCULAR HYPERTENSION - CHANGING CONCEPTS IN MANAGEMENT
    LIBERTINO, JA
    POSTGRADUATE MEDICINE, 1984, 75 (03) : 149 - &